-+ 0.00%
-+ 0.00%
-+ 0.00%

Clearmind says Johns Hopkins IRB clears next stages of CMND-100 Phase I/II trial

PUBT·05/26/2026 12:25:25
Listen to the news
Clearmind says Johns Hopkins IRB clears next stages of CMND-100 Phase I/II trial
  • Johns Hopkins Medicine IRB cleared the CMND-100 Phase I/II trial to move into Parts B and C.
  • The multicenter study tests single and multiple doses in healthy volunteers, then Alcohol Use Disorder patients.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605260825PRIMZONEFULLFEED9726400) on May 26, 2026, and is solely responsible for the information contained therein.